Sanitary Valve Market to Exceed $3.4 Billion in 2015


The sales of valves to meet the rigid requirements of the pharmaceutical, food and other life science industries in 2015 will exceed $3.4 billion worldwide. This is the last forecast in Industrial Valves World Market published by the McIlvaine Company.

Sanitary Valve Market to Exceed $3.4 Billion in 2015

McIlvaine Company

Traditionally, Europe and the U.S. have been the big markets for pharmaceutical valves. The rapid construction of generic manufacturing facilities in India and China, along with a general trend to build manufacturing facilities close to the market, is creating a market shift toward Asia.

Much of the growth in food processing is also in Asia where there is a growth in production along with greater concern for contamination. This increases the average sales price per valve as more expensive materials of construction and more expensive designs are needed. The food industry also has need for valves which can withstand the higher temperatures associated with safe processing.

"Other Life Sciences" include cosmetics and a number of small niche applications. Valves used in hospitals are not included in these industrial forecasts.

The market for valves for municipal drinking water plants in 2015 will be more than $3.8 billion. However, these valves are not designed to the high sanitary levels required of valves in the life sciences. One reason is that disinfection is a common method of protection of drinking water, but is not acceptable as a way to treat fluids processed in the life sciences.

The life sciences segment of the valve market has grown more steadily and at a higher rate than the average segment.

More articles on this topic

Editorial: Diaphragm Metering Pumps for Critical Mixing Tasks in Industrial Oligonucleotide Production

23.04.2024 -

The demands on production systems for medically necessary oligonucleotides are high. Chemical resistance and biological integrity are just as important today as enormous flexibility in order to be able to synthesise a wide variety of drugs. With its special diaphragm metering pumps, LEWA GmbH guarantees compliance with these requirements even for critical mixing tasks and, in addition to standardised platform technologies, even provides customer-specific GMP-compliant systems.

Read more